Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Hypertension and Sleep Disordered Breathing in Pediatrics

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2010 by Winthrop University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Winthrop University Hospital
ClinicalTrials.gov Identifier:
NCT00990899
First received: October 6, 2009
Last updated: May 11, 2010
Last verified: May 2010
  Purpose

The primary objective is to determine the prevalence of sleep disordered breathing in children with primary hypertension or pre hypertension. The secondary objectives are to determine any association factors for children with primary hypertension or prehypertension to have sleep disordered breathing be it gender, age, body mass index (BMI), family history (hx) or ethnic group.


Condition
Hypertension
Obstructive Sleep Apnea

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: Hypertension and Sleep Disordered Breathing in Pediatrics

Resource links provided by NLM:


Further study details as provided by Winthrop University Hospital:

Estimated Enrollment: 50
Study Start Date: October 2008
Estimated Study Completion Date: October 2010
Estimated Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
Detailed Description:

This is an exploratory, cross sectional study involving identification of the children of the age between 10 years and 17 years diagnosed with primary hypertension who have not been previously diagnosed and or treated for sleep disordered breathing with the revised pediatric sleep questionaire (PSQ) for sleep disordered breathing. The subjects that have shown interest will be mailed the informed consent/assent form to tbe reviewed. The consent/assent form will be handed to the child and all their questions and concerns will be answered in a comprehensible manner.

  Eligibility

Ages Eligible for Study:   10 Years to 17 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

children aged 10 to 17 years who have been diagnosed with primary hypertension

Criteria

Inclusion Criteria:

  • aged 10 to 17 years old diagnosed with primary hypertension

Exclusion Criteria:

  • refused to participate in the study
  • children to secondary hypertension
  • previously diagnosed with sleep disordered breathing
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00990899

Contacts
Contact: Melodi Pirzada, MD 516-663-4600 mpirzada@winthrop.org
Contact: Roopa Siddaiah, MBBS 516-663-4600 rsiddaiah@winthrop.org

Locations
United States, New York
Winthrop University Hospital Recruiting
Mineola, New York, United States, 11501
Contact: MELODI PIRZADA, MD    516-663-4600    mpirzada@winthrop.org   
Sponsors and Collaborators
Winthrop University Hospital
Investigators
Principal Investigator: Melodi Pirzada, MD Winthrop University Hospital
  More Information

No publications provided

Responsible Party: Pirzada, Melodi, MD, Winthrop-University Hospital
ClinicalTrials.gov Identifier: NCT00990899     History of Changes
Other Study ID Numbers: 08025
Study First Received: October 6, 2009
Last Updated: May 11, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Winthrop University Hospital:
hypertension
obstructive sleep apnea
pediatrics

Additional relevant MeSH terms:
Hypertension
Respiratory Aspiration
Sleep Apnea Syndromes
Sleep Apnea, Obstructive
Apnea
Cardiovascular Diseases
Dyssomnias
Nervous System Diseases
Pathologic Processes
Respiration Disorders
Respiratory Tract Diseases
Sleep Disorders
Sleep Disorders, Intrinsic
Vascular Diseases

ClinicalTrials.gov processed this record on November 24, 2014